Dental technology company Align Technology (NASDAQ: ALGN) reported Q3 2026 results topping the market’s revenue expectations, with sales up 1.9% year on year to $1.01 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less impressive, coming in 3.7% below analysts’ estimates. Its non-GAAP profit of $2.80 per share was 1.3% above analysts’ consensus estimates.

Is now the time to buy ALGN? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Align Technology’s third quarter results were shaped by a combination of resilient Clear Aligner demand and shifts in product mix, particularly toward lower-priced scanner configurations. Management cited record doctor participation and increased shipments among both orthodontists and general practitioners, along with expanding international growth as key drivers. CEO Joe Hogan highlighted that, despite a challenging environment for discretionary dental spending, “record doctor submitters” and improved utilization contributed to the company’s ability to grow sales volumes. Discipline around expense management and productivity also supported an improved operating margin versus last year.

Looking ahead, Align Technology’s forward guidance reflects ongoing caution around consumer demand for elective dental procedures and continued pressure on capital equipment sales. Management attributed its conservative outlook to persistent softness in patient traffic and a greater proportion of lower-priced offerings, particularly in its scanner and services business. CFO John Morici emphasized that “product and geographic mix, along with foreign exchange, are expected to weigh on average selling prices,” while efforts to expand patient financing and new product launches, such as the 3D-printed sports mouthguard, are seen as vital to driving future adoption. The company is also preparing for a CEO transition, with Jennifer Davis set to take the helm at year-end.

Key insights from management’s remarks

Management attributed the latest quarter’s results to increased Clear Aligner utilization, expanding international demand, and strategic shifts in its scanner portfolio, while also highlighting the impact of affordability initiatives and digital workflow integration.

• Record doctor participation: Align reported a new high in doctor submitters for Invisalign cases, reflecting growing engagement among orthodontists and general practitioners globally. Management pointed to a 3% year-over-year increase in doctor participation and noted particularly strong adoption in younger patient segments.

• International market strength: Double-digit shipment growth was achieved in both the EMEA (Europe, Middle East, and Africa) and APAC (Asia-Pacific) regions, with teens and younger patients driving significant volume, especially in China and Latin America. CEO Joe Hogan credited the expansion of digital workflows and targeted marketing campaigns as key contributors to this momentum.

• Shift toward lower-priced scanner models: The Systems and Services segment saw continued adoption of flexible acquisition models, such as leasing and certified preowned scanners. This shift, though reducing average selling prices, helped expand Align’s installed base and lowered barriers for new doctor customers to access digital technology.

• Affordability and financing initiatives: The company’s Zero Additional Aligner (Zero AA) offering and expanded patient financing partnerships delivered triple-digit growth in usage. These programs are designed to make Invisalign treatment more accessible to patients otherwise deterred by cost.

• Digital platform and AI integration: Align continues to invest in connecting its iTero scanning technology, AI-driven treatment planning, and restorative workflows. Management highlighted the Invisalign Advanced Restorative Treatment (ART) as a tool to broaden the company's reach beyond orthodontics and into comprehensive dental care.

Drivers of future performance

Align Technology’s outlook is shaped by persistent consumer caution, a shift in sales mix, and the need to drive adoption through product innovation and affordability.

• Soft demand for elective procedures: Management expects discretionary dental spending to remain subdued globally, which could limit near-term growth for both Clear Aligners and capital equipment. CEO Joe Hogan noted, “we see a challenged market…not just in North America, but different parts of the world.”

• Product mix and pricing pressure: The company anticipates continued growth in lower-priced products and geographies, which is likely to weigh on average selling prices and compress margins. CFO John Morici explained that volume gains in markets like India and China, while positive, generate lower revenue per case compared to developed markets.

• New product launches and financing: Initiatives such as the 3D-printed sports mouthguard and expanded patient financing are expected to support case conversion and broaden Align’s addressable market, though the impact will depend on execution and adoption rates across distribution channels.

Catalysts in upcoming quarters

In the quarters ahead, the StockStory team will focus on (1) the pace of adoption and profitability for new product offerings like the 3D-printed sports mouthguard, (2) stabilization or growth in scanner and services revenue as the company shifts to more flexible acquisition models, and (3) early signs of increased patient conversion tied to expanded financing options and affordability initiatives. The CEO transition to Jennifer Davis will also be a closely watched development.

Align Technology currently trades at $153.59, in line with $153.62 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

Our favorite stocks right now

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.